Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Richard C. Dodel"'
Autor:
Carmen Noelker, Lydie Morel, Thomas Lescot, Anke Osterloh, Daniel Alvarez-Fischer, Minka Breloer, Carmen Henze, Candan Depboylu, Delphine Skrzydelski, Patrick P. Michel, Richard C. Dodel, Lixia Lu, Etienne C. Hirsch, Stéphane Hunot, Andreas Hartmann
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/a91445e21ab14f96bc53d7295845dfaf
Autor:
Johannes Levin, Eva Schäffer, Alexander Kurz, Franziska Hopfner, Günther Deuschl, Klaus Jahn, Christina Lang, Matthias Höllerhage, Christiane Weck, Daniela Berg, Günter Höglinger, D. Huster, Franz Brettner, Andres O. Ceballos-Baumann, A. Gerhard, Richard C. Dodel, Kai Bötzel, Stefan Lorenzl, Saskia Kammenhuber, Wolfgang H. Jost, Georg Ebersbach, Johannes Schwarz, Gesine Respondek, Aurelia Peraud, Bernhard Haslinger, Timo Grimmer, Georg Nübling, Jürgen Winkler, Grit Mallien, Franz Marxreiter, Sylvia Maaß, Ulrike Reuner, Angela Jochim, Jan Kassubek, Christine Klein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b807897ee0bd0e5868eefdf85c508e9b
https://doi.org/10.1055/b-006-161664
https://doi.org/10.1055/b-006-161664
Autor:
Richard C Dodel, Guenter F. Pilz, Susanne Rinné, Bilgen Kurt, Andreas Maieron, Muhidien Soufi, Juergen R. Schaefer, Tobias Mueller, Niels Decher, Volker Ruppert
Publikováno v:
Neurology Genetics. 4:e274
ObjectiveTo identify the genetic basis of a patient with symptoms of normokalemic sporadic periodic paralysis (PP) and to study the effect of KCNJ18 mutations.MethodsA candidate gene approach was used to identify causative gene mutations, using Sange
Autor:
Paul A. Hyslop, Steven M. Paul, Zhiyuan Zhang, Kelly R. Bales, Richard C. Dodel, Michele Glinn, Binhui Ni, Yansheng Du
Publikováno v:
Journal of Neurochemistry. 69:299-305
The beta-amyloid peptide (A beta) is a normal proteolytic processing product of the amyloid precursor protein, which is constitutively expressed by many, if not most, cells. For reasons that are still unclear, A beta is deposited in an aggregated fib
Publikováno v:
Neuroscience Letters. 315:61-64
Minocycline, a semisynthetic second-generation tetracycline, was reported to have neuroprotective effects in models of global and focal cerebral ischemia, the R6/2 mouse model of Huntington disease, as well as glutamate-induced neurotoxicity in mixed
Autor:
Kelly R. Bales, Steven M. Paul, Josep Saura, Valérie Petegnief, Bernardino Ghetti, Richard C. Dodel, Yansheng Du, Tatyana Verina, Pedro Piccardo, David J. Cummins, Cindy E. Fishman, Cynthia DeLong
Publikováno v:
Proceedings of the National Academy of Sciences. 96:15233-15238
We quantified the amount of amyloid β-peptide (Aβ) immunoreactivity as well as amyloid deposits in a large cohort of transgenic mice overexpressing the V717F human amyloid precursor protein ( APP V717F+/− TG mice) with no, one, or two mouse apoli
Autor:
Karin Briner, Richard C. Dodel
Publikováno v:
Current Pharmaceutical Design. 4:291-302
Abstract: The challenges for the design of new antidepressant drugs are threefold: rapid onset of antidepressant response, broader efficacy, and fewer adverse effects. While progress has been made to reduce side-effects, the currently available drugs
Autor:
Wolfgang H. Oertel, Richard C. Dodel, Marika S. Singer, Tobias E. Eichhorn, Oliver Pogarell, Karla Eggert
Publikováno v:
Movement Disorders. 13:249-254
Parkinson's disease (PD) has a major socioeconomic impact on society. The chronic, progressive course of the disease, which often leads to severe disability, results in high expenses for the medical resources used for treatment, care, and rehabilitat
Autor:
Richard C. Dodel, Wolfgang H. Oertel, B Rathay, R Selzer, W Scholz, R Köhne-Volland, M Singer
Publikováno v:
Der Nervenarzt. 68:978-984
Parkinson's disease (PD) causes significant expense for the national health care system due to its chronic progressive course, the duration of the disease, the high prevalence and the devastating prognosis. In Germany more than DM 320 million are spe
Autor:
Rudolf Koehne-Volland, Annette Kirchner, Gabriella Künig, Allison Brashear, Wolfgang H. Oertel, Markus Naumann, Andres O. Ceballos-Baumann, Richard C. Dodel, Hans P. Richter, Thomas D. Szucs
Publikováno v:
PharmacoEconomics. 12:695-706
Botulinum toxin (BTX) has become a safe and effective therapeutic tool in the treatment of a variety of neurological disorders, especially dystonias. One major disadvantage, however, is the high cost of a single injection of BTX. In this study of 835